Leading cancer researchers from around the world are working together to catalogue the genetic changes of the 50 most common cancers.
Fifty of the most common cancers are to be cataloged by some of the world's leading cancer researchers.
They say it's the first step towards developing personalised cancer treatments.
Personalised Cancer Treatment May No Longer be Wishful Thinking
Researchers at the University of California, San Diego School of Medicine have devised a system capable of delivering siRNA into primary cells.
Researchers at the University of California, San Diego School of Medicine have devised a system capable of delivering siRNA into primary cells.
"The consortium is providing the global research community with the best possible research tool - how to select the next clinical trial. Whole genome sequencing allows us to pinpoint the exact molecular aberrations of each tumour. Understanding the aberrations allows you to target them with drugs," said author Andrew Biankin.
"For example, you might find that the aberrations in a subtype of colon cancer are the same as the aberrations in a subtype of melanoma. In that case, the treatment that works in the colon cancer may be appropriate for the melanoma. So you'd go ahead and test it."
Personalised Cancer Treatment on the Anvil
Researchers from University of Chicago have discovered a genetic signature that may help predict whether a patient will respond to cancer therapies - a finding that may pave way for
Researchers from University of Chicago have discovered a genetic signature that may help predict whether a patient will respond to cancer therapies - a finding that may pave way for
"When we treat a cancer, we give a person the drug that's most likely to work - within the limitations of our current understanding. The drug may not work for that individual, even though it works for the majority of patients with the same kind of cancer.
Advertisement
Researchers Find an Antibody to Improve Ovarian Cancer Treatment
Austrian researchers have found an antibody that could be used to step up the fight against ovarian cancer -- a major killer for women.
Austrian researchers have found an antibody that could be used to step up the fight against ovarian cancer -- a major killer for women.
"The consortium's internet-based databanks will help us treat specific cancers with specific treatments. Not only that, the information will help us understand why some treatments work and others do not, and then design better drugs to target faulty elements or mechanisms," he added.
Advertisement
New Aggressive Breast Cancer Treatment Study Launched in US
To test new treatments for aggressive breast cancer, a rare alliance between the US government and five major drug companies, researchers launched a clinical study Wednesday.
To test new treatments for aggressive breast cancer, a rare alliance between the US government and five major drug companies, researchers launched a clinical study Wednesday.
Source-ANI
TAN
